Residual Disease Burden After Neoadjuvant Therapy Among US Patients With High-Risk HER2-positive Early-Stage Breast Cancer: A Population Effectiveness Model
-
Published:2022-12
Issue:8
Volume:22
Page:781-791
-
ISSN:1526-8209
-
Container-title:Clinical Breast Cancer
-
language:en
-
Short-container-title:Clinical Breast Cancer
Author:
Hendrix NathanielORCID,
Oestreicher Nina,
Lalla Deepa,
Dolan Chantal M.,
Fisher Kathryn A.,
Veenstra David L.,
Moy Beverly
Subject
Cancer Research,Oncology
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献